Advertisement
Advertisement

BHC

BHC logo

Bausch Health Companies Inc

5.74
USD
Sponsored
+0.15
+2.59%
Jan 30, 15:58 UTC -5
Closed
exchange

After-Market

5.72

-0.01
-0.17%

BHC Earnings Reports

Positive Surprise Ratio

BHC beat 22 of 40 last estimates.

55%

Next Report

Date of Next Report
Feb 18, 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.74B
/
$1.28
Implied change from Q3 25 (Revenue/ EPS)
+2.04%
/
+11.30%
Implied change from Q4 24 (Revenue/ EPS)
+6.91%
/
+12.28%

Bausch Health Companies Inc earnings per share and revenue

On Oct 29, 2025, BHC reported earnings of 1.15 USD per share (EPS) for Q3 25, beating the estimate of 1.13 USD, resulting in a 2.59% surprise. Revenue reached 2.68 billion, compared to an expected 2.66 billion, with a 0.65% difference. The market reacted with a +12.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of 1.28 USD, with revenue projected to reach 2.74 billion USD, implying an increase of 11.30% EPS, and increase of 2.04% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Teva Pharmaceutical Industries Limited - ADR
Report Date
Jan 28, 2026 For Q4 25
Estimate
$0.69
Actual
$0.96
Surprise
+38.55%
logo
Dr. Reddy's Laboratories Limited - ADR
Report Date
Jan 21, 2026 For Q3 26
Estimate
$13.86
Actual
$14.65
Surprise
+5.66%
FAQ
For Q3 2025, Bausch Health Companies Inc reported EPS of $1.15, beating estimates by 2.59%, and revenue of $2.68B, 0.65% above expectations.
The stock price moved up 12.03%, changed from $5.90 before the earnings release to $6.61 the day after.
The next earning report is scheduled for Feb 18, 2026.
Based on 5 analysts, Bausch Health Companies Inc is expected to report EPS of $1.28 and revenue of $2.74B for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement